GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

AX · Jun 30, 2023

Axos Financial, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001299709-23-000198Bank
Sequential deposit growth30thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

2.30% · CORE · VALID

Net-income growth80thOwn-history percentile · N=15
Evidence method

Yoy · gp.fundamentals.net_income

27.60% · CORE · VALID

Interest-expense growth100thOwn-history percentile · N=15
Evidence method

Yoy · gp.financial.interest_expense

611.46% · CORE · VALID

Interest-income growth100thOwn-history percentile · N=15
Evidence method

Yoy · gp.financial.interest_income

75.40% · CORE · VALID

Cash and equivalents95thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$2.4B · CORE · VALID

Sequential loan growth59thOwn-history percentile · N=17
Evidence method

Sequential · gp.financial.loans

3.92% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History27 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
6.68%
Current
2.30%
Delta
-4.39%
Liquidity Decreased
Previous
$2.5B
Current
$2.4B
Delta
-$122.1M
Loan Growth Increased
Previous
2.35%
Current
3.92%
Delta
1.57%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.